πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 68 of 173

  1. US 10077442

    Bioactive renal cells

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10077424

    Methods of producing RPE cells and compositions of RPE cells

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10077300

    Activatable binding polypeptides and methods of identification and use thereof

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10077236

    Azacyclic constrained analogs of FTY720

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10077271

    Methods and compositions for inhibiting the interaction of menin with MLL proteins

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10076562

    Methods for treating plague

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10076538

    Compositions comprising citrate and applications thereof

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10076533

    Acyclic nucleoside phosphonate diesters

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10076520

    Use of tyrosine kinase inhibitor in cancer treatment

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10076532

    Acyclic nucleoside phosphonate diesters

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10076509

    Nested particles and the use thereof for coordinated delvery of active agents

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10072243

    Derivation of embryonic stem cells and embryo-derived cells

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10073109

    Phages of biomarker capture and methods of use

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10072022

    Oridonin analogs, compositions, and methods related thereto

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10071943

    Copper catalyzed [18F]fluorination of iodonium salts

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10071110

    Phosphonate compounds

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10071101

    Use of cinnabarinic acid as a modulator of immune response in autoimmune disorders

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10071142

    Enzymes and methods for cleaving N-glycans from glycoproteins

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10072062

    Methods and compositions for modification of a HLA locus

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10064942

    Copper-cysteamine and methods of use

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10064914

    Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10064894

    Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10064889

    Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10064862

    Antiviral axin stabilizer

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10064958

    Nipah virus envelope pseudotyped lentiviruses and methods of their use

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10058561

    Methods and related compositions for reduction of fat and skin tightening

    Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10058572

    Placenta-derived multipotent stem cells

    Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10053706

    Parental RNAi suppression of chromatin remodeling genes to control coleopteran pests

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10053494

    Chemically activated nanocapsid functionalized for cancer targeting

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10052349

    Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10052393

    Multifunctional nanomaterials for the treatment of cancer

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10047396

    Biomarkers for diagnosis of transient ischemic attacks

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10047125

    Peptide having activity to improve skin condition and use thereof

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10046057

    Methods for arranging and packing nucleic acids for unusual resistance to nucleases and targeted delivery for gene therapy

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10046036

    Chemically modified cystathionine Ξ²-synthase enzyme for treatment of homocystinuria

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10046068

    Saccharide conjugates

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10046016

    Mutant adeno-associated virus virions and methods of use thereof

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10045990

    ERBB4 inhibitors and methods of use thereof

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10046045

    Vaccine compositions and uses thereof

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10041936

    Neuronal cells cultured on microparticles and methods of using same

    Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10040769

    HDAC inhibitors for the treatment of diabetic peripheral neuropathy

    Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10039816

    Siderophore-based immunization against gram-negative bacteria

    Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10039725

    Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene

    Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10041041

    Compositions and methods for treating retinal diseases

    Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10039807

    bFGF-polymer conjugates, methods for making the same and applications thereof

    Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10035981

    Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10035823

    Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10035846

    Humanized pertussis antibodies and uses thereof

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.